Medicure Inc. (CVE:MPH – Get Free Report) shares crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$0.88 and traded as low as C$0.79. Medicure shares last traded at C$0.79, with a volume of 1,000 shares.
Medicure Price Performance
The firm has a 50-day simple moving average of C$0.79 and a 200 day simple moving average of C$0.88. The firm has a market cap of C$8.24 million, a PE ratio of -4.05 and a beta of 0.90. The company has a debt-to-equity ratio of 4.65, a current ratio of 2.03 and a quick ratio of 1.29.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
See Also
- Five stocks we like better than Medicure
- How to Start Investing in Real Estate
- MarketBeat Week in Review – 03/24 – 03/28
- What is a Death Cross in Stocks?
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What is a Special Dividend?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
